Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Amortizatization of Intangibles (2023 - 2025)

Historic Amortizatization of Intangibles for Cumberland Pharmaceuticals (CPIX) over the last 3 years, with Q3 2025 value amounting to $285184.0.

  • Cumberland Pharmaceuticals' Amortizatization of Intangibles changed 0.0% to $285184.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 1627.94%. This contributed to the annual value of $1.1 million for FY2024, which is 3669.72% up from last year.
  • Cumberland Pharmaceuticals' Amortizatization of Intangibles amounted to $285184.0 in Q3 2025, which was down 0.0% from $285185.0 recorded in Q2 2025.
  • Cumberland Pharmaceuticals' 5-year Amortizatization of Intangibles high stood at $296150.0 for Q2 2023, and its period low was $125479.0 during Q4 2023.
  • For the 3-year period, Cumberland Pharmaceuticals' Amortizatization of Intangibles averaged around $257344.6, with its median value being $285184.0 (2024).
  • Examining YoY changes over the last 5 years, Cumberland Pharmaceuticals' Amortizatization of Intangibles showed a top increase of 12727.71% in 2024 and a maximum decrease of 370.25% in 2024.
  • Quarter analysis of 3 years shows Cumberland Pharmaceuticals' Amortizatization of Intangibles stood at $125479.0 in 2023, then soared by 127.28% to $285185.0 in 2024, then dropped by 0.0% to $285184.0 in 2025.
  • Its last three reported values are $285184.0 in Q3 2025, $285185.0 for Q2 2025, and $285184.0 during Q1 2025.